P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
2,375.00
+40.00 (1.71%)
At close: May 14, 2026
P&K Skin Research Center Market Cap
P&K Skin Research Center has a market cap or net worth of 68.59 billion as of May 15, 2026. Its market cap has increased by 10.98% in one year.
Market Cap
68.59B
Enterprise Value
30.50B
Revenue
22.78B
Ranking
n/a
PE Ratio
14.64
Stock Price
2,375.00
Market Cap Chart
Since September 9, 2020, P&K Skin Research Center's market cap has decreased from 201.07B to 68.59B, a decrease of -65.89%. That is a compound annual growth rate of -17.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 68.59B | -7.23% |
| Dec 30, 2025 | 73.94B | 21.62% |
| Dec 30, 2024 | 60.80B | -17.65% |
| Dec 28, 2023 | 73.83B | -18.95% |
| Dec 29, 2022 | 91.08B | -33.84% |
| Dec 30, 2021 | 137.67B | -19.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 474.25B |
| DreamCIS | 182.54B |
| HLB bioStep | 107.65B |
| WOOJUNG BIO | 49.82B |
| C&R Research | 39.42B |
| DT&CRO CO. | 37.07B |
| SLS BIO | 26.89B |
| BioInfra | 19.43B |